Lipocine (LPCN) Total Liabilities (2011 - 2025)
Lipocine's Total Liabilities came in at $2.53 million for Q4 2025, up 67.1% from $1.51 million a year earlier and up 30.9% from the prior quarter.
Powered by 
Analysis
Lipocine (LPCN) Total Liabilities (2011 - 2025) Analysis & Trends
Going back to Q4 2011, Lipocine's Total Liabilities data covers 56 quarters.
- Total Liabilities carries a five-year compound annual growth rate of -24.1% (FY2020 to FY2025).
- Going back by year, Total Liabilities was $1.51 million in FY2024 (-42.5%), $2.63 million in FY2023 (+37.9%), $1.91 million in FY2022 (-72.4%) and $6.91 million in FY2021 (-31.0%).
- The Q4 2025 figure represents the highest quarterly Total Liabilities since Q4 2023.
- Year-over-year, Total Liabilities increased in two of the last eight quarters, with an average decline of 6.3%.
- The fastest year-over-year change in Total Liabilities over five years came in Q4 2025 (growth of 67.1%), and the weakest in Q2 2022 (a decline of 79.9%).
- Business Quant data shows LPCN's Total Liabilities at $1.93 million (Q3 2025), $1.45 million (Q2 2025) and $1.3 million (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 116.09 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 141.05 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 87.82 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 80.09 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 65.46 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 83.95 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 37.53 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 115.64 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 7.18 Bn |
| 10 | Lipocine | 11.33 Mn | -56.39 Mn | - | 2.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 2.53 Mn |
| Sep 30, 2025 | 1.93 Mn |
| Jun 30, 2025 | 1.45 Mn |
| Mar 31, 2025 | 1.30 Mn |
| Dec 31, 2024 | 1.51 Mn |
| Sep 30, 2024 | 1.58 Mn |
| Jun 30, 2024 | 1.82 Mn |
| Mar 31, 2024 | 1.49 Mn |
| Dec 31, 2023 | 2.63 Mn |
| Sep 30, 2023 | 2.27 Mn |
| Jun 30, 2023 | 1.93 Mn |
| Mar 31, 2023 | 2.06 Mn |
| Dec 31, 2022 | 1.91 Mn |
| Sep 30, 2022 | 1.78 Mn |
| Jun 30, 2022 | 2.30 Mn |
| Mar 31, 2022 | 5.19 Mn |
| Dec 31, 2021 | 6.91 Mn |
| Sep 30, 2021 | 7.58 Mn |
| Jun 30, 2021 | 11.43 Mn |
| Mar 31, 2021 | 8.19 Mn |
API Access
Lipocine Total Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-liabilities&ticker=LPCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-liabilities", "ticker": "LPCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-liabilities&ticker=LPCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();